Tuberculosis (TB) immune reconstitution inflammatory syndrome (IRIS) affects 20% of patients with TB and HIV after antiretroviral therapy (ART) initiation. It is associated with significant morbidity and its pathogenesis is still not fully elucidated. We identified differentially expressed RNA transcripts between TB/HIV co-infected patients with and without IRIS.
Subjects in this cohort study (NCT01611402) were TB/HIV co-infected and had been on TB treatment and ART. Blood was collected in PAXgene tubes at the time of TB-IRIS or, for those without IRIS, at 8-12 weeks after ART initiation, then cryopreserved. RNA was extracted and hybridized on the Affymetrix GeneChip® Human Gene 2.0 ST array. The chip was then stained and scanned. Expression of transcripts was compared using ANOVA with multiple test correction using Benjamini–Hochberg false discovery rate method. Ingenuity Pathway Analysis (IPA) was used to identify canonical pathways and upstream regulators.
Patients with (n=6), and without (n=10) TB-IRIS were enrolled. Patient characteristics are listed in Table 1. Patients with TB-IRIS had higher plasma HIV viral load (p=0.01), C-reactive protein (p=0.02) and absolute neutrophil count (p<0.001) and lower hemoglobin (p<0.001). Using p<0.05 as cut off, compared with patients with no IRIS, patients with IRIS had 355 differentially expressed transcripts, of which 167 had ≥ ±2 fold difference (148 up and 19 down regulated). IPA showed that innate antigen recognition signaling pathways including inflammasome (p=4.27e-6), TREM1 (p=2.70e-5) and Toll-Like Receptor signaling (p=4.13e-5) were the top over-represented pathways in TB IRIS. Upstream regulator analysis predicted Transglutaminase 2 (activated, z-score 2.8, p=9.06e-6), interferon-Υ (activated, z-score 2.3, p=1.22e-4) and interferon regulatory factor 4 (inhibited, z-score -2.0, p=1.63e-4) to be potential upstream regulators of the aforementioned pathways and that the activation of these pathways would lead to an increase in caspase 1 breakdown of pro-interleukin (IL) 1b to IL-1b, resulting in a pro-inflammatory response.
Using RNA microarray analysis, transcripts of innate antigen recognition and signaling pathways were over expressed and likely play a crucial role in TB-IRIS. The use of agents that block inflammasome and IL-1b signaling in recalcitrant TB-IRIS merit further investigation.